National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 5460-5461 [2020-01741]
Download as PDF
<![CDATA[
5460
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
Dated: January 24, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01640 Filed 1–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Hemostasis
and Thrombosis.
Date: February 21, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Larry Pinkus, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkusl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–17–
240: Innovative Research in Cancer
Nanotechnology.
Date: February 25, 2020.
Time: 7:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW, Washington, DC 20037.
Contact Person: Amy Kathleen Wernimont,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198,
Bethesda, MD 20892, 301–827–6427,
amy.wernimont@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Academic Research Enhancement Award
(AREA).
Date: February 25, 2020.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
16:56 Jan 29, 2020
Jkt 250001
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, 301–827–5902,
caojn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
20–004: Molecular Mechanisms of BloodBrain Barrier Function and Dysfunction in
Alzheimer’s Disease and Alzheimer’s Related
Dementias (AD/ADRD).
Date: February 26, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Linda MacArthur, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, 301–537–9986,
macarthurlh@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 27, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01735 Filed 1–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Ipolia R. Ramadan, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, Room 4228, MSC 95509529,
Bethesda, MD 20892, 301–827–4471,
ramadanir@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Phase II
Topic 163.
Date: February 20, 2020.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Blvd., Room 4245,
Rockville, MD 20852, 301–827–5817,
mcguireso@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 27, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01743 Filed 1–29–20; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; SBIR
Phase II, Topic 164: Development of Portable
Neuromodulatory Devices for the Treatment
of Substance Use Disorders (8948).
Date: February 19, 2020.
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\30JAN1.SGM
30JAN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: NIAMS
AMS Member SEP Conflict Review Meeting.
Date: February 25, 2020.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy
Boulevard, Suite 816, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Nakia C. Brown, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy
Boulevard, Room 816, Bethesda, MD 20892,
(301) 827–4905, brownnac@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: NIAMS
AMSC Member Conflict Panel.
Date: March 11, 2020.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy
Boulevard, Suite 812, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy
Boulevard, Suite 812, Bethesda, MD 20892,
(301) 451–4838, mak2@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: NIAMS
RISK R61 Skin and Rheumatic Disease
Review Meeting.
Date: March 27, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy
Boulevard, Suite 600, Room 602, Bethesda,
MD 20892.
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy
Boulevard, Suite 812, Bethesda, MD 20892,
(301) 451–4838, mak2@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: NIAMS
RISK R61 Musculoskeletal Diseases (MSK)
Review Meeting.
Date: March 31, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy
Boulevard, Suite 800, Room 803, Bethesda,
MD 20892.
VerDate Sep<11>2014
16:56 Jan 29, 2020
Jkt 250001
Contact Person: Yin Liu, Ph.D., M.D.,
Scientific Review Branch, National Institute
of Health, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Suite 824, Bethesda,
MD 20892, (301) 594–8919, liuy@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: January 27, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–01741 Filed 1–29–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2020–0004; OMB No.
1660–0107]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; FEMA Public
Assistance Customer Satisfaction
Surveys
Federal Emergency
Management Agency, DHS.
ACTION: Notice and request for
comments.
AGENCY:
The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public to take this opportunity
to comment on a revision of a currently
approved information collection. In
accordance with the Paperwork
Reduction Act of 1995, this notice seeks
comments concerning the collection of
Public Assistance customer satisfaction
survey responses and information for
assessment and improvement of the
delivery of disaster assistance to States,
Local and Tribal governments, and
eligible non-profit organizations.
DATES: Comments must be submitted on
or before March 30, 2020.
ADDRESSES: To avoid duplicate
submissions to the docket, please use
only one of the following means to
submit comments:
(1) Online. Submit comments at
www.regulations.gov under Docket ID
FEMA–2020–0004. Follow the
instructions for submitting comments.
(2) Mail. Submit written comments to
Docket Manager, Office of Chief
Counsel, DHS/FEMA, 500 C Street SW,
8NE, Washington, DC 20472–3100.
SUMMARY:
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
5461
All submissions received must
include the agency name and Docket ID.
Regardless of the method used for
submitting comments or material, all
submissions will be posted, without
change, to the Federal eRulemaking
Portal at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. You may wish to read the
Privacy and Security Notice that is
available via a link on the homepage of
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Kristin Brooks, Statistician, Customer
Survey Analysis Section, Reporting and
Analytics Division, Recovery
Directorate, at (940) 891–8579 or
kristin.brooks@fema.dhs.gov. You may
contact the Information Management
Division for copies of the proposed
collection of information at email
address: FEMA-Information-CollectionsManagement@fema.dhs.gov.
SUPPLEMENTARY INFORMATION: This
collection is in accordance with
Executive Orders 12862 and 13571
requiring all Federal agencies to survey
customers to determine the kind and
quality of services they want and their
level of satisfaction with existing
services. The Government Performance
and Results Act of 1993 (GPRA) requires
Federal agencies to set missions and
goals and to measure agency
performance against them. See Public
Law 103–62, 107 Stat 285 (1993). The
GPRA Modernization Act of 2010
requires quarterly performance
assessments of government programs for
the purposes of assessing agency
performance and improvement. See
Public Law 111–352, 124 Stat 3875
(2011). The Federal Emergency
Management Agency fulfills these
requirements by collecting customer
satisfaction program information
through surveys of States, Local and
Tribal governments, and eligible nonprofit organizations.
Collection of Information
Title: FEMA Public Assistance
Customer Satisfaction Surveys.
Type of Information Collection:
Revision of a currently approved
information collection.
OMB Number: 1660–0107.
FEMA Forms: FEMA Form 519–0–32,
Public Assistance Initial Customer
Satisfaction Survey (Telephone); FEMA
Form 519–0–33, Public Assistance
Initial Customer Satisfaction Survey
(internet); FEMA Form 519–0–34,
Public Assistance Assessment Customer
Satisfaction Survey (Telephone); FEMA
Form 519–0–35, Public Assistance
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 85, Number 20 (Thursday, January 30, 2020)]
[Notices]
[Pages 5460-5461]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01741]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 5461]]
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: NIAMS AMS
Member SEP Conflict Review Meeting.
Date: February 25, 2020.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701 Democracy Boulevard,
Suite 816, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Nakia C. Brown, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National Institutes of Health,
6701 Democracy Boulevard, Room 816, Bethesda, MD 20892, (301) 827-
4905, [email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: NIAMS AMSC
Member Conflict Panel.
Date: March 11, 2020.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701 Democracy Boulevard,
Suite 812, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Kan Ma, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National Institutes of Health,
6701 Democracy Boulevard, Suite 812, Bethesda, MD 20892, (301) 451-
4838, [email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: NIAMS RISK
R61 Skin and Rheumatic Disease Review Meeting.
Date: March 27, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701 Democracy Boulevard,
Suite 600, Room 602, Bethesda, MD 20892.
Contact Person: Kan Ma, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National Institutes of Health,
6701 Democracy Boulevard, Suite 812, Bethesda, MD 20892, (301) 451-
4838, [email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel: NIAMS RISK
R61 Musculoskeletal Diseases (MSK) Review Meeting.
Date: March 31, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, National Institutes of Health, 6701 Democracy Boulevard,
Suite 800, Room 803, Bethesda, MD 20892.
Contact Person: Yin Liu, Ph.D., M.D., Scientific Review Branch,
National Institute of Health, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Suite
824, Bethesda, MD 20892, (301) 594-8919, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: January 27, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-01741 Filed 1-29-20; 8:45 am]
BILLING CODE 4140-01-P
